Consistency among different PSMA ligands for defining PSMA-overexpression prior to PSMA-targeted therapy in prostate cancer

被引：0
|
作者：
Heilinger, Jan [1 ,2 ]
Weindler, Jasmin [3 ]
Roth, Katrin [1 ,2 ]
Krapf, Philipp [4 ]
Neumaier, Bernd [5 ,6 ]
Schomaecker, Klaus
Dietlein, Markus
Drzezga, Alexander [7 ,8 ]
Kobe, Carsten
机构：
[1] Univ Cologne, Fac Med, Dept Nucl Med, Cologne, Germany
[2] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[3] Univ Cologne, Dept Nucl Med, Cologne, Germany
[4] INM 5, Julich, Germany
[5] Univ Cologne, Inst Radiochem & Expt Mol Imaging, Cologne, Germany
[6] Forschungszentrum Julich, Nucl Chem, Inst Neurosci & Med INM 5, Julich, Germany
[7] Univ Hosp Cologne, Dept Nucl Med, Cologne, Germany
[8] Inst Neurosci & Med INM 2, Mol Org Brain, Julich, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
241353
引用
收藏
页数：3
相关论文
共 50 条
  • [1] PSMA-Targeted Therapy in Prostate Cancer
    Tagawa, Scott T.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (02)
  • [2] PSMA-targeted radioligand therapy in prostate cancer
    Heck, M. M.
    Retz, M.
    Tauber, R.
    Knorr, K.
    Kratochwil, C.
    Eiber, M.
    UROLOGE, 2017, 56 (01): : 32 - 39
  • [3] Do you know your PSMA-tracer? Variability in the biodistribution of different PSMA ligands and its potential impact on defining PSMA-positivity prior to PSMA-targeted therapy
    Heilinger, Jan
    Roth, Katrin Sabine
    Weis, Henning
    Fink, Antonis
    Weindler, Jasmin
    Dietlein, Felix
    Krapf, Philipp
    Schomaecker, Klaus
    Neumaier, Bernd
    Dietlein, Markus
    Drzezga, Alexander
    Kobe, Carsten
    EJNMMI RESEARCH, 2025, 15 (01):
  • [4] Advances in PSMA-targeted therapy for prostate cancer
    Fujin Wang
    Zhifeng Li
    Xiaoqian Feng
    Dazhuang Yang
    Mei Lin
    Prostate Cancer and Prostatic Diseases, 2022, 25 : 11 - 26
  • [5] PSMA-Targeted Radiopharmaceuticals for Prostate Cancer Diagnosis and Therapy
    Oldan, Jorge D.
    Almaguel, Frankis
    Voter, Andrew F.
    Duran, Alfonso
    Gafita, Andrei
    Pomper, Martin G.
    Hope, Thomas A.
    Rowe, Steven P.
    CANCER JOURNAL, 2024, 30 (03): : 176 - 184
  • [6] PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy of Prostate Cancer
    V. K. Tishchenko
    V. M. Petriev
    O. P. Vlasova
    V. V. Krylov
    P. V. Shegai
    S. A. Ivanov
    A. D. Kaprin
    Physics of Atomic Nuclei, 2022, 85 : 1608 - 1612
  • [7] PSMA-Targeted Theranostic Nanoplex for Prostate Cancer Therapy
    Chen, Zhihang
    Penet, Marie-France
    Nimmagadda, Sridhar
    Li, Cong
    Banerjee, Sangeeta R.
    Winnard, Paul T., Jr.
    Artemov, Dmitri
    Glunde, Kristine
    Pomper, Martin G.
    Bhujwalla, Zaver M.
    ACS NANO, 2012, 6 (09) : 7752 - 7762
  • [8] PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy of Prostate Cancer
    Tishchenko, V. K.
    Petriev, V. M.
    Vlasova, O. P.
    Krylov, V. V.
    Shegai, P. V.
    Ivanov, S. A.
    Kaprin, A. D.
    PHYSICS OF ATOMIC NUCLEI, 2022, 85 (09) : 1608 - 1612
  • [9] Correction to: Advances in PSMA-targeted therapy for prostate cancer
    Fujin Wang
    Zhifeng Li
    Xiaoqian Feng
    Dazhuang Yang
    Mei Lin
    Prostate Cancer and Prostatic Diseases, 2022, 25 (1) : 130 - 130
  • [10] Defining the clinical utility of PSMA-targeted PET imaging of prostate cancer
    Gorin, Michael A.
    Pomper, Martin G.
    Pienta, Kenneth J.
    Rowe, Steven P.
    BJU INTERNATIONAL, 2017, 120 (02) : 160 - 161
12345